Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
Sharh maqola

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. PostumaDepartment of Neurology Montreal General Hospital Montreal Quebec CanadaDaniela BergDepartment of Neurodegeneration Hertie‐Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases Tuebingen GermanyMatthew SternPenn Neurological Institute Philadelphia Pennsylvania USAWerner PoeweDepartment of Neurology Innsbruck Medical University Innsbruck AustriaC. Warren OlanowDepartment of Neurology The Mount Sinai Hospital New York New York USAWolfgang H. OertelDepartment of Neurology Philipps University of Marburg Marburg GermanyJosé Á. ObesoUniversity of Navarra‐FIMA Pamplona SpainKenneth MarekInstitute for Neurodegenerative Disorders New Haven Connecticut USAIrene LitvanDepartment of Neurosciences UC San Diego La Jolla California USAAnthony E. LangDivision of Neurology Toronto Western Hospital Toronto Ontario CanadaGlenda M. HallidayNeuroscience Research Australia & University of NSW Randwick AustraliaChristopher G. GoetzRush University Medical Center Chicago Illinois USAThomas GasserDepartment of Neurodegeneration Hertie‐Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases Tuebingen GermanyBruno DuboisHopital De La Salpetriere Paris FrancePiu ChanXuanwu Hospital of Capitol of Medical University Beijing Peoples Republic of ChinaBastiaan R. BloemDepartment of Neurology, Radboud University Medical Center Donders Institute for Brain, Cognition and Behaviour Nijmegen NetherlandsCharles H. AdlerThe Parkinson's Disease and Movement Disorders Center, Department of Neurology Mayo Clinic Scottsdale Arizona USAGünther DeuschlDepartment of Neurology Christian‐Albrechts University Kiel Germany
2015en
ABI

Annotatsiya

This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in clinical research but also may be used to guide clinical diagnosis. The benchmark for these criteria is expert clinical diagnosis; the criteria aim to systematize the diagnostic process, to make it reproducible across centers and applicable by clinicians with less expertise in PD diagnosis. Although motor abnormalities remain central, increasing recognition has been given to nonmotor manifestations; these are incorporated into both the current criteria and particularly into separate criteria for prodromal PD. Similar to previous criteria, the Movement Disorder Society PD Criteria retain motor parkinsonism as the core feature of the disease, defined as bradykinesia plus rest tremor or rigidity. Explicit instructions for defining these cardinal features are included. After documentation of parkinsonism, determination of PD as the cause of parkinsonism relies on three categories of diagnostic features: absolute exclusion criteria (which rule out PD), red flags (which must be counterbalanced by additional supportive criteria to allow diagnosis of PD), and supportive criteria (positive features that increase confidence of the PD diagnosis). Two levels of certainty are delineated: clinically established PD (maximizing specificity at the expense of reduced sensitivity) and probable PD (which balances sensitivity and specificity). The Movement Disorder Society criteria retain elements proven valuable in previous criteria and omit aspects that are no longer justified, thereby encapsulating diagnosis according to current knowledge. As understanding of PD expands, the Movement Disorder Society criteria will need continuous revision to accommodate these advances.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba